Union européenne - français - EMA (European Medicines Agency)

gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Union européenne - français - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antiviraux à usage systémique - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - sacituzumabum govitecanum - poudre pour solution à diluer pour perfusion - praeparatio cryodesiccata: sacituzumabum govitecanum 180 mg, acidum morpholinoethansulfonicum, trehalosum dihydricum, polysorbatum 80, pro vitro. - le cancer du sein - biotechnologika

Union européenne - français - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - agents antinéoplasiques - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Canada - français - Health Canada

gilead sciences canada inc - sacituzumab govitécan - poudre pour solution - 180mg - sacituzumab govitécan 180mg - antineoplastic agents

Union européenne - français - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - infections au vih - antiviraux à usage systémique - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 et 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 et 5.

Canada - français - Health Canada

gilead sciences canada inc - lénacapavir (lénacapavir sodique) - comprimé - 300mg - lénacapavir (lénacapavir sodique) 300mg

Canada - français - Health Canada

gilead sciences canada inc - lénacapavir (lénacapavir sodique) - solution - 309mg - lénacapavir (lénacapavir sodique) 309mg

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - lenacapavirum - solution injectable - lenacapavirum 463.5 mg ut lenacapavirum natricum, macrogolum 300, aqua ad iniectabile, ad solutionem pro 1.5 ml corresp. natrium 10.99 mg. - l'infection à vih - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

gilead sciences switzerland sàrl - lenacapavirum - comprimés pelliculés - lenacapavirum 300 mg ut lenacapavirum natricum, copovidonum, poloxamerum 407, mannitolum, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (flavum), e 172 (nigrum), e 172 (rubrum), pro compresso obducto corresp. natrium max. 17.93 mg. - l'infection à vih - synthetika